Bioassay guided purification of the antimicrobial fraction of a Brazilian propolis from Bahia state
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
26/08/2013
26/08/2013
2009
|
Resumo |
Abstract Background Brazilian propolis type 6 (Atlantic forest, Bahia) is distinct from the other types of propolis especially due to absence of flavonoids and presence of other non-polar, long chain compounds, but presenting good in vitro and in vivo antimicrobial activity. Several authors have suggested that fatty acids found in this propolis might be responsible for its antimicrobial activity; however, so far no evidence concerning this finding has been reported in the literature. The goals of this study were to evaluate the antibacterial activity of the main pure fatty acids in the ethanolic extract and fractions and elucidate the chemical nature of the bioactive compounds isolated from Brazilian propolis type 6. Methods Brazilian propolis type 6 ethanolic extract (EEP), hexane fraction (H-Fr), major fatty acids, and isolated sub-fractions were analyzed using high performance liquid chromatography (HPLC), high resolution gas chromatography with flame ionization detection (HRGC-FID), and gas chromatography-mass spectrometry (GC-MS). Three sub-fractions of H-Fr were obtained through preparative HPLC. Antimicrobial activity of EEP, H-Fr, sub-fractions, and fatty acids were tested against Staphyloccus aureus ATCC 25923 and Streptococcus mutans Ingbritt 1600 using minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). Results EEP and H-Fr inhibited the growth of the microorganisms tested; nevertheless, no antimicrobial activity was found for the major fatty acids. The three sub-fractions (1, 2, and 3) were isolated from H-Fr by preparative HPLC and only sub-fraction 1 showed antimicrobial activity. Conclusion a) The major fatty acids tested were not responsible for the antimicrobial activity of propolis type 6; b) Sub-fraction 1, belonging to the benzophenone class, was responsible for the antimicrobial activity observed in the present study. The identification of the bioactive compound will improve the development of more efficient uses of this natural product. The authors thank FAPESP (Proc. No. 04/109921), CNPq (131758/20063), FAPEMIG (EDT240/05), and Mr. José Elpidio de Mendonça Cerqueira, Naturapi – Produtos Naturais e Apícolas Ltda., for providing the propolis samples. The authors thank FAPESP (Proc. No. 04/10992-1), CNPq (131758/2006-3), FAPEMIG (EDT-240/05), and Mr. José Elpidio de Mendonça Cerqueira, Naturapi – Produtos Naturais e Apícolas Ltda., for providing the propolis samples. |
Identificador |
1472-6882 http://www.producao.usp.br/handle/BDPI/32926 10.1186/1472-6882-9-25 |
Idioma(s) |
eng |
Relação |
BMC Complementary and Alternative Medicine |
Direitos |
openAccess Castro et al; licensee BioMed Central Ltd. - This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
Tipo |
article original article |